TrialScope, the global leader in clinical trial transparency and compliance solutions, announced new findings from its sponsor survey on clinical trial results sharing practices, at CBI’s second annual Plain Language Summit in Philadelphia.The survey asked sponsors about their current approach to trial results summaries and their plans for sharing summaries in the future.

Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has completed the expansion of the laboratory facility within its USA headquarters located in the Research Triangle area of North Carolina.

Schmolz + Bickenbach Announces $49.96 Million Investment in Swiss Steel

Celgene is abandoning late-stage testing of its experimental drug mongersen for Crohn’s disease after a Data Monitoring Committee concluded that it would be futile to continue. The drugmaker confirmed the untimely end of the Phase III REVOLVE trial and the extension trial SUSTAIN following an interim assessment of the drug’s overall benefit/risk profile.

Schmolz + Bickenbach Announces $49.96 Million Investment in Swiss Steel

Myeloma UK has launched a nationwide trial aiming to assess the effectiveness of a novel treatment combination that includes Darzalex for patients with genetically-defined high-risk myeloma.The trial, which will take place at 30 Clinical Trial Network (CTN) centres across the UK, is split into two parts.